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Abstract:  Fragile X syndrome is caused by dynamic mutation of FMR1 gene CpG island CGG repeats. The underlying mutational mechanism is 
not fully understood. Different microsatellite markers and SNP have previously been reported as markers associated with FMR1 CGG 
repeat instability. The aim of the present study was to identify specific haplotypes among Latvian FXS patients and the control group 
with respect to allelic stability. Eleven male FXS patients and 122 control male patients participated in the study. In total, 27 different 
DXS548-FRAXAC1-ATL1-FRAXAC2 haplotypes were found. The prevalent haplotype in the control group was 7-4-A-5+ (rel. frequency 
0.327). The prevalent haplotype associated with the FXS group was 2-2-G-4 (rel. frequency 0.818; p < 0.0001). Grey zone alleles with 
a long uninterrupted CGG tract at the 3’ end were significantly associated with the 2-2-G-4 haplotype (p = 0.0022). Our findings sug-
gest that, for the Latvian population, the haplotype 2-2-G-4 is a marker of CGG tract instability. We conclude that a founder effect could 
not be an explanation for our findings on the basis of heterogeneity exhibited by the Latvian population and lack of studies throughout 
this geographical region. This data may provide evidence of different mutational pathways of expansion in the Baltic States region. 
                   © Versita Sp. z o.o.
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1. Introduction 
Fragile X syndrome (FXS; OMIM #300624; FRAXA, 
Xq27.3) is a well known common cause of X-linked 
mental retardation. The prevalence of FXS full mutation 
is 1/4000 - 6000 males and 1/8000 - 10000 females. 
The syndrome is caused by a dynamic mutation of 
FMR1 gene CpG island CGG repeats [1-4]. Among in-
dividuals from the general population, the polymorphic 
CGG repeat ranges from 6 to 50 repeats and is usu-
ally interspersed every 9–10 repeats with an AGG [5,6]. 
Premutation alleles have a moderate expansion of the 
repeat (from 50 to ~200 units), they are unmethylated 
on an active X chromosome and do not affect FMR1 
expression. CGG repeat expansion over 200 is the ba-
sis for CpG island methylation, leading to silencing of 
the FMR1 gene [7]. Intermediate or grey zone alleles 
are poorly defined. Boundaries for the grey zone range 
vary among studies, from 34 or 35 CGG repeats for the 
lower boundary to 58/60 repeats for the upper boundary 
[7-10]. These alleles are often transmitted stably, but are 
more likely to exhibit unstable transmission with increas-
ing size within this range.
 The underlying mutational mechanism is not fully 
understood and remains a topic of debate. The gender 
of the parent carrying an expanded repeat (maternal im-
printing), the number of repeats (dynamic mutation) and 
the absence of AGG interruptions in long tracts of CGG 
repeats have been described as the main factors relat-
ed to this instability [5,9,11]. The microsatellite markers 
DXS548-FRAXAC1-FRAXAC2 and the ATL1 SNP have 
previously been reported as markers associated with 
FMR1 CGG repeat instability [5,12-17].
 Haplotypes linked to FXS are widely described 
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across Western European and Scandinavian popula-
tions; however, less is known regarding populations 
from Eastern Europe, including the Baltic States. The 
aim of the present study was to identify specific haplo-
types among Latvian FXS patients and control mental 
retardation patients with a normal number of CGG re-
peats with respect to allelic stability. 
2. Material and Methods
2.1. Patients
Eleven unrelated male FXS patients, confirmed by DNA 
analysis, participated in this study. The control group 
comprised of 122 unrelated male patients exhibiting 
mental retardation, referred by clinical geneticists for 
routine FRAXA screening, with a normal number of 
FMR1 CGG repeats. The Latvian Central Committee of 
Medical Ethics and the Riga Stradins University Com-
mittee of Medical Ethics approved the study.
2.2 Analysis of the CGG repeat and AGG 
interspersion pattern Haplotype analysis
The CGG repeat number was determined by fluorescent 
PCR on an ABI Prism® 310 genetic analyser following 
the manufacturer’s protocol (Applied Biosystems, USA). 
Twenty-six patients with grey zone alleles (35–50 repe-
ats) were detected and subsequently selected for AGG 
interspersion pattern analysis by direct sequencing.
 For CGG repeat pattern analysis, the flanking DNA 
sequences were amplified from genomic DNA using the 
PCR protocol described by Chong et al. [17] PCR pro-
ducts were concentrated and purified for the sequencing 
reaction by a Millipore Montage PCR filter device.
 The sequencing reaction was performed using a 
BigDye® Terminator v3.1 kit (Applied Biosystems) ac-
cording to the manufacturer’s protocol. Due to the high 
G/C content of the template, 1 μl of DMSO and 0.5 μl 
of glycerol were added to the reaction. The primer used 
was 5’-GAC GGA GGC GCC GCT GCC AGG-3’ [19]. 
The reaction was carried out on a PCR Eppendorf Ma-
stercycler. Subsequent purification of the sequencing 
products was performed as recommended by the ma-
nufacturer. All sequencing reaction products were run 
on an ABI Prism® 310 genetic analyser and analysed 
by ABI DNA sequencing software.
2.3. Haplotype analysis
The ATL1 polymorphism (alleles A/G located 5613 bp 
upstream of the CGG repeat) was analysed by follow-
ing the allele-specific oligonucleotide PCR protocol de-
scribed by Dombrowski et al. [11]. 
 Case-control haplotype analysis between the FXS 
patients and the control group was performed using the 
microsatellite markers DXS548, FRAXAC1 and FRAX-
AC2. The DXS548 microsatellite is located 189895 bp 
downstream of the CGG repeat, the FRAXAC1 microsat-
ellite is located 7221 bp downstream of the CGG repeat 
and the FRAXAC2 microsatellite is located 12418 bp 
upstream of the CGG repeat. Multiplex PCR for DXS548 
and FRAXAC2 was performed in a total reaction volume 
of 15 μl, containing 1× PCR reaction buffer (75 mM Tris-
HCl (pH 8.8 at 25°C), 20 mM (NH4)2SO4, 0.01% Tween 
20), 1.5 mM MgCl2, 0.2 mM of each dNTP, 7% glycerol, 
2 pmol of each primer DXS548A (5’-HEX-AGA GCT 
TCA CTA TGC AAT GGA ATC-3’) and DXS548B (5’-GTA 
CAT TAG AGT CAC CTG TGG TGC-3’) [20], 1 pmol 
of each primer FRAXAC2A (5’-6-FAM-GAC TGC TCC 
GGA AGT TGA ATC CTC A-3’) and FRAXAC2B (5’-CTA 
GGT GAC AGA GTG AGA TCC TGT C-3’) [20], and 0.15 
U True startTM Hot Start Taq DNA polymerase. PCR 
was carried out by an initial step of 2 min at 95°C, then 
10 cycles of 30 sec at 95°C, 1 min at 60°C and 1 min at 
72°C. This was followed by a second round of amplifica-
tion comprising 25 cycles of 30 sec at 95°C, 1 min at 
55°C and 1 min at 72°C, and a final extension at 72°C 
for 7 min.
 The FRAXAC1 microsatellite marker was amplified 
separately with 4.5 pmol of primer FRAXAC1A (5’-NED-
GAT CTA ATC AAC ATC TAT AGA CTT TAT T-3’) and 
FRAXAC1B (5’-AGA TTG CCC ACT GCA CTC CAA 
GCC T-3’) [20] under the same PCR conditions.
 Multiplex reaction product (0.5 μl) was mixed with an 
equal volume of GeneScan™ ROX 500™ size standard 
and 24 μl of deionised formamide. The lengths of prod-
uct fragments were determined on an ABI Prism® 310 
genetic analyser.
 Genotyping results were analysed by GeneScan® 
Analysis software. The corresponding peak’s length 
was calculated according to the calibration curve of Ge-
neScan™ ROX 500™ size standard. Nomenclature for 
alleles was adjusted to the nomenclature recommended 
by Macpherson et al. [14].
 Genotyping results were validated by direct se-
quencing of random alleles for each microsatellite mark-
er. For each marker allele, the same PCR conditions 
as described above for genotyping were used, except 
the reverse primers A were not labelled with fluorescent 
dye. PCR products were concentrated and purified for 
the sequencing reaction by a Millipore Montage PCR 
filter device.
 The sequencing reaction was performed using a Big-
Dye® Terminator v3.1 kit according to the manufactur-
er’s protocol. The reaction was carried out on a PCR 
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Eppendorf Mastercycler. Subsequent purification of the 
sequencing products was performed as recommended 
by the manufacturer. All sequencing reaction products 
were run on an ABI Prism® 310 genetic analyser and 
analysed by ABI DNA sequencing software.
2.3. Statistics
The statistical calculations of AMOVA for the haplotype 
analysis and level of heterozygosity for all polymorphisms 
were done using Arlequin 3.5 software [21]. Comparison 
of obtained data was performed by Fisher’s exact test 
of 2×2 contingency tables and chi-square (http://www.
graphpad.com/quickcalcs/index.cfm). The differences 
were considered statistically significant at p < 0.05. In 
case-control analysis Bonferroni correction was applied 
for multiple testing. 
3. Results
3.1. ATL1 SNP
The control group CGG repeat alleles were analysed 
with respect to ATL1 alleles. The control group was di-
vided into two subgroups according to CGG allele re-
peat number – normal size alleles and grey zone alleles 
(Table 1). The relative frequency (RF) of allele A in the 
normal subgroup was 0.563, for allele G it was 0.438. In 
the grey zone subgroup, allele A had a RF of 0.308, for 
allele G the RF was 0.692. Allele G differed significantly 
between normal size alleles and grey zone alleles (p = 
0.0271).
 A statistically significant association between indi-
vidual CGG alleles and the ATL1 SNP was found for 
allele 29 and G (p = 0.001); 30 CGG repeats and A 
(p < 0.0001) and allele 31 and A (p = 0.0013).
 All FXS group chromosomes were found to be exclu-
sively associated with ATL1 allele G, and this associa-
tion was statistically significant (p = 0.0008).
3.2. Repeat structures of grey zone alleles
Twenty-six grey zone alleles were sequenced in order 
to characterise the AGG interruption within the CGG 
repeat. Twelve chromosomes exhibited a CGG inter-
spersion pattern with three AGG, 12 chromosomes with 
two AGG, one chromosome with one AGG and one pure 
CGG tract (Table 2). For all chromosomes, the loss of 
AGG was detected at the 3’ end of the sequence.
3.3. DXS548-FRAXAC1-ATL1-FRAXAC2 
haplotypes
Several microsatellite markers and the ATL1 SNP were 
analysed in the FXS patient group and the control group. 
Seven different microsatellite alleles were detected with 
respect to the DXS548 locus, four alleles were identi-
fied regarding the FRAXAC1 locus and nine alleles 
were found for the FRAXAC2 locus. The frequencies of 
the described alleles in the control and FXS group are 





Grey zone CGG alleles
(35–50 repeats)
ATL1 n RF n RF
A 54 0.563 8 0.308
G 42 0.438 18 0.692*
Total 96 1.000 26 1.000
Table 1. Frequencies of the ATL1 SNP in CGG Alleles.
n = number of chromosomes; RF = relative frequency; * p < 0.05
DXS548 FRAXAC1 ATL1 FRAXAC2 CGG AGG n RF
2 2 G 4 38 9+9+18 8 0.308**
  39 9+29  
  40 9+9+20  
  40 9+9+20  
  41 9+9+21  
  45 9+9+25  
  47 9+9+27  
  50 9+9+30  
7 4 A 5+ 39 10+9+9+8 6 0.231
  41 10+9+9+10  
  41 10+9+10+9  
  41 10+9+10+9  
  42 10+9+21  
  43 10+9+22  
6 5 G 7+ 37 9+10+6+9 2 0.077
  38 Pure  
7 4 G 6+ 39 9+9+9+9 2 0.077
  39 9+9+9+9  
7 4 G 5 39 9+9+9+9 2 0.077
  39 9+9+9+9  
6 4 G 5 41 9+9+21 2 0.077
  42 9+9+22  
6 5 A 7 37 9+10+6+9 1 0.038
6 4 A 5+ 35 10+6+8+8 1 0.038
3 2 G 4 38 9+9+18 1 0.038
7 4 G 5+ 36 10+9+5+9 1 0.038
Total           26 1.000
Table 2.  AGG Interspersion Pattern and Linked DXS548-FRAXAC1-
ATL1-FRACXAC2 Haplotype Frequencies of Grey Zone 
CGG Alleles.
RF = relative frequency; AGG = pattern of CGG tract, the digit corresponds 
to the CGG repeat number and ‘+’ denotes the AGG interspersion position; 
** p < 0.01.
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 The level of heterozygosity for all polymorphisms 
was examined under finite island model and compa-
red (Table 3). 
 The identified markers were combined to form ha-
plotypes. In total, 27 different haplotypes were detected 
– 26 in the control group, three in the FXS group. Only 
one haplotype from the FXS group was unique (Table 4). 
The most common haplotype among the control group 
chromosomes was 7-4-A-5+ (RF = 0.327; p = 0.0336). 
Among FXS patients, the prevalent haplotype was 2-2-
G-4 (RF = 0.818; p < 0.0001).
 Statistical analysis of the data revealed that the mo-
lecular variation between the groups was 27.04% and 
within the groups was 72.96%. The fixation index Fst, 
calculated based on haplotype frequencies between the 
control and FXS group, was 0.27042.
 A haplotype analysis based on the CGG tract pat-
tern in grey zone alleles was performed (Table 2). The 
most common haplotypes in this subgroup were 2-2-G-4 
(RF = 0.308) and 7-4-A-5+ (RF = 0.231). All the alleles 
with 2-2-G-4 haplotype had a long (≥ 18 CGG repeats) 
uninterrupted sequence at the 3’ end (p = 0.0022). Six 
alleles out of 18 with other detected haplotypes had the 
same feature.
4. Discussion
Our study is the first study in the Baltic States region 
regarding FMR1 linked haplotypes. In the present study, 
we characterised the microsatellite markers DXS548, 
FRAXAC1 and FRAXAC2, the ATL1 SNP and the cor-
responding haplotypes in a mentally retarded male pop-
ulation from Latvia with normal and expanded FMR1 
gene CGG repeats.
 Previous studies have suggested linkage of CGG 
tract instability with the G allele of ATL1, specific mic-
rosatellite marker haplotypes and a CGG tract AGG in-
terspersion pattern exhibiting a long uninterrupted CGG 
repeat at the 3’ end [5,11,22-25]. Our results revealed a 
statistically significant prevalence of the G allele of ATL1 
among grey zone alleles and full mutation alleles as an 
indicator of instability.
 The AMOVA data suggested that the differences be-
tween detected haplotypes within the control and FXS 
group were significant. In our Latvian population, 7-4-A-
5+ was determined as the prevalent haplotype for nor-




Mean S.D. HT HO X
2 p-value
ATL1 SNP 0.504 0.000 0.252 0.356 0.501 0.696 20.332 <0.0001
FRAXAC1 0.501 0.327 0.414 0.123 0.545 0.863 53.654 <0.0001
FRAXAC2 0.734 0.327 0.530 0.288 0.757 1.055 62.591 <0.0001
DXS548 0.546 0.182 0.364 0.258 0.594 1.009 94.310 <0.0001
Table 3. Expected Heterozygosity and Observed Heterozygosity 
among the Control and FXS Groups.
HE = expected heterozygosity; HT = total heterozygosity;
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mal CGG alleles. However, after Bonferroni correction, 
this finding was not considered to be statistically signif-
icant. Furthermore, haplotype 2-2-G-4 was found to be 
in positive association with full mutation CGG alleles 
and grey zone alleles featuring a long (≥18 repeats) 
uninterrupted CGG tract at the 3’ end. These findings 
imply that, in our population, haplotype 2-2-G-4 is a 
marker of CGG tract instability. Grey zone alleles with 
a long uninterrupted CGG tract at the 3’ end associated 
with this haplotype have a higher likelihood of increas-
ing the number of CGG repeats, leading to premutation 
or mutation over generations.
 Several studies have identified specific haplotypes 
associated with FXS patients and normal CGG repeat 
alleles across European populations [22,25-29]. How-
ever, only a limited number of these studies focused 
on populations from Eastern and Northeastern Europe. 
Different loci were used for these haplotype analyses 
in European populations. Thus, comparison of our re-
sults with these analyses would prove difficult. There-
fore, we compared the results presented here with 
single locus data in the literature. 
 Allele 7 at the DXS548 locus was the most common 
allele (RF = 0.639) in our control group. Similar findings, 
albeit with slightly different frequencies, have been re-
ported from Sweden [27], Czech Republic [28], Finland 
[30], France [16], Croatia [25], Russia [31], Norway [32] 
and Poland [29]. In contrast, our finding with respect to 
the most common allele in FXS patients (allele 2, RF = 
0.909) was in agreement with only one of the analyses 
(Polish population, allele 2; Swedish population, alleles 
7 and 6; Czech population, alleles 2, 6 and 7; French 
population, alleles 2, 6 and 7; Finnish population, almost 
exclusively allele 6; Croatian population, alleles 7, 6 and 
3; Norwegian population, alleles 6 and 2). 
 For the FRAXAC1 locus, allele 4 was the most com-
mon allele (RF = 0.664) in our control group. Analysis of 
this locus in control chromosomes of a Czech popula-
tion revealed allele 3 to be the most common allele [28]. 
This was also the case in populations from Russia [31], 
Haplotype Control group  FXS group
DXS548 FRAXAC1 ATL1 FRAXAC2 n RF SD n RF SD
7 4 A 5+ 40 0.327 0.043 0   - - 
7 5 G 7 11 0.090 0.026 0   - - 
2 2 G 4 9 0.074 0.024 9 0.818*** 0.122
7 4 G 5 8 0.066 0.023 1 0.091 0.091
7 4 G 6+  8 0.066 0.023 0  - - 
6 4 A 5+  7 0.057 0.021 0  - - 
6 5 G 7 6 0.049 0.020 0  - - 
6 5 G 7+  6 0.049 0.020 0  - - 
8 4 A 5+  3 0.025 0.014 0  - - 
3 2 G 4 3 0.025 0.014 0  - - 
5 4 A 5+  2 0.016 0.012 0  - - 
7 5 G 7+  2 0.016 0.012 0  - - 
7 4 G 5+  2 0.016 0.012 0  - - 
7 4 A 4+  2 0.016 0.012 0  - - 
6 4 G 5 2 0.016 0.012 0  - - 
6 5 A 5+  1 0.008 0.008 0  - - 
3 4 G 6+  1 0.008 0.008 0  - - 
7 4 A 5 1 0.008 0.008 0  - - 
7 4 G 7 1 0.008 0.008 0  - - 
7 3 A 5+  1 0.008 0.008 0  - - 
6 4 A 4+  1 0.008 0.008 0  - - 
7 4 A 3 1 0.008 0.008 0  - - 
7 4 A 3+  1 0.008 0.008 0  - - 
9 4 A 5+  1 0.008 0.008 0  - - 
6 5 G 6+  1 0.008 0.008 0  - - 
6 5 A 7 1 0.008 0.008 0  - - 
2 4 G 5  0 -  -  1 0.091 0.091
Total       122 1.000 0.374 11 1.000 0.304
Table 4. Frequencies of DXS548-FRAXAC1-ATL1-FRAXAC2 Haplotypes in the Control and FXS Group.
n = number of chromosomes; RF = relative frequency; SD = standard deviation; *** p < 0.0001
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Norway [32] and Croatia [25], while alleles 3 and 4 were 
prevalent in a Polish population [29]. Regarding Latvian 
FXS chromosomes, we found allele 2 to be the most 
common allele (RF = 0.818). However, this was not in 
line with the findings from other populations (Norwegian, 
allele 4; Polish, allele 4; Croatian, allele 3; Czech, alleles 
3 and 4). 
 Compared to the microsatellite marker FRAXAC1, 
the FRAXAC2 locus has been more widely used in stud-
ies. Allele 5+ was the most common allele at this locus in 
our control group, detected at a RF of 0.467. This finding 
was not replicated in other populations: Finnish, allele 3 
[30]; Swedish, Czech and French, allele 4+ [16,26,28]; 
Polish, alleles 7 and 7+ [29]. The prevalent allele in our 
FXS patients was allele 4. Allele 3 was identified in half 
of the investigated chromosomes in a Finnish FXS pa-
tient group, while alleles 4+ and 5 were prevalent in a 
Swedish population, alleles 4+ and 4 in a Czech popula-
tion, alleles 3 and 4 in a French population, and allele 7 
in a Polish population.
 In summary, our finding regarding allele 7 be-
ing the most common allele at the DXS548 locus in 
Latvian control patients is in line with several other 
European population control groups. Furthermore, 
our FXS patient group finding (i.e. allele 2 being the 
prevalent allele at this locus) is consistent with data 
from a Polish FXS population. The FRAXAC1 and 
FRAXAC2 loci results for our control and FXS group 
differ to varying degrees from the data reported for 
other European populations.
 As the analysed microsatellite loci and nomen-
clature assigned to alleles in the literature are dif-
ferent, confusion arises, which may lead to bias in 
the interpretation of literature data comparing hap-
lotypic results from different populations.
 To the best of our knowledge, specific FMR1-linked 
haplotypes in the Baltic State region and Northeastern 
Europe have not been previously described. The pres-
ent study is the first to report Latvian population FMR1 
haplotype data. Comparison of the data with those ob-
tained from geographically close European populations 
highlights differences, particularly with the FXS patient 
group. Indeed, haplotype 2-2-G-4 appears to be exclu-
sively found in Latvian FXS chromosomes. A small sam-
ple size making up the case group may have a negative 
effect on this result.
 We conclude that a founder effect could not be an 
explanation of our findings on the basis of heterogene-
ity exhibited by the Latvian population and lack of stud-
ies across this geographical region. A larger study of 
FMR1-linked haplotypes in Eastern and Northeastern 
European regions may provide evidence of a specific 
mutational pathway for unstable CGG alleles in this geo-
graphical region.
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